Sojuzpatent Successfully Represents Sucampo AG (Switzerland) in Biopharmaceutical Patent Case

14 February 2019

On February 14, 2019, the Chamber for patent disputes ruled in favor of our client – a patent-holding company Sucampo AG in a patent invalidation case. 

Sucampo AG operates as a subsidiary of Sucampo Pharmaceuticals, Inc. (USA), an important biopharmaceutical company and major manufacturer of medicines for gastroenterology, ophthalmology, and oncology-related disorders. Our team protected our client’s patent rights for lubiprostone and related inventions.